z-logo
open-access-imgOpen Access
Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2
Author(s) -
Sho Moriguchi,
Harumasa Takano,
Yasuyuki Kimura,
Tomohisa Nagashima,
Keisuke Takahata,
Manabu Kubota,
Soichiro Kitamura,
Tatsuya Ishii,
Masanori Ichise,
Ming-Rong Zhang,
Hitoshi Shimada,
Masaru Mimura,
Jeffrey H. Meyer,
Makoto Higuchi,
Tetsuya Suhara
Publication year - 2017
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyx069
Subject(s) - norepinephrine transporter , duloxetine , norepinephrine , serotonin transporter , positron emission tomography , reuptake inhibitor , medicine , serotonin plasma membrane transport proteins , endocrinology , pharmacology , chemistry , serotonin , nuclear medicine , dopamine , pathology , receptor , alternative medicine
The norepinephrine transporter in the brain has been targeted in the treatment of psychiatric disorders. Duloxetine is a serotonin and norepinephrine reuptake inhibitor that has been widely used for the treatment of depression. However, the relationship between dose and plasma concentration of duloxetine and norepinephrine transporter occupancy in the human brain has not been determined. In this study, we examined norepinephrine transporter occupancy by different doses of duloxetine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom